PMID: 9187486Jun 1, 1997Paper

Dopamine-induced apoptosis is inhibited in PC12 cells expressing Bcl-2

Cellular and Molecular Neurobiology
D OffenA Barzilai

Abstract

1. Degeneration of nigrostriatal dopaminergic neurons is the major pathogenic substrate of Parkinson's disease (PD). It is assumed that the lethal trigger is the accumulation of oxidative reactive species generated during metabolism of the natural neurotransmitter dopamine. 2. We have recently shown that dopamine is capable of inducing programmed cell death (PCD) or apoptosis in cultured postmitotic chick sympathetic neurons and rat PC12 pheochromocytoma cells. 3. The bcl-2 gene encodes a protein which blocks physiological PCD in many mammalian cells. In an attempt to elucidate further the mechanism of dopamine toxicity, we examined the potential protective effect of bcl-2 in PC12 cells which were transfected with the protooncogene. 4. In our experiments, Bcl-2 producing cells showed a marked resistance to dopamine toxicity. The percentage of nuclear condensation and DNA fragmentation visualized by the end-labeling method following dopamine treatment was significantly lower in bcl-2 expressing cells. Bcl-2 did not protect PC12 cells against toxicity induced by exposure to dopamine-melanin. Extracts of PC12 cells containing Bcl-2 inhibited dopamine autooxidation and formation of dopamine-melanin. Furthermore, the presence of Bcl...Continue Reading

Citations

Jan 22, 2005·Acta Pharmacologica Sinica·Xiao-chun ChenLi-min Chen
Oct 5, 2010·The Journal of Biological Chemistry·Dong ChenGuanghui Wang
Nov 25, 1998·Movement Disorders : Official Journal of the Movement Disorder Society·I Ziv, E Melamed
May 20, 1998·Proceedings of the National Academy of Sciences of the United States of America·D OffenO Bernard
Aug 26, 1999·Journal of Neurochemistry·A ShirvanA Barzilai
Nov 15, 2000·American Journal of Physiology. Lung Cellular and Molecular Physiology·V J Thannickal, B L Fanburg
Jun 23, 2001·Drugs & Aging·W D Le, J Jankovic
Jun 29, 2006·Neurochemical Research·Cristina Gómez-SantosSantiago Ambrosio
Sep 27, 2006·Pituitary·Joseph E Ippolito
Aug 24, 2000·The Journal of Biological Chemistry·R Zilkha-FalbA Shirvan
Jul 18, 2003·Journal of Neuroscience Research·Cristina Gómez-SantosSantiago Ambrosio
Jul 5, 2005·Expert Opinion on Investigational Drugs·D Gurwitz
Mar 31, 1999·Proceedings of the National Academy of Sciences of the United States of America·M YamadaD J Fink
Mar 13, 2014·Journal of Neurosurgery. Spine·Hamed Reihani KermaniMajid Asadi-Shekaari
Oct 1, 2015·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Cheuk-Kwan SunPo-Han Chen
Apr 29, 1999·Journal of Neuroscience Research·A H StokesK E Vrana
Nov 10, 2000·Brain Research. Molecular Brain Research·A ShirvanA Barzilai
Jun 26, 1998·Brain Research. Brain Research Reviews·B Connor, M Dragunow
Nov 6, 2002·Biochemical Pharmacology·Federico De MarcoMaria Anna Rosei
May 19, 2009·Biochemical Pharmacology·Hanit Brenner-LavieDorit Ben-Shachar

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis